SOX9 and prostate carcinoma: Accounting for 100% of all infections, G7191T and G7518A mutations, were predicted by Xi et al. [31] to be, respectively, the binding sites for FOXA1 (Forkhead box protein A1), which is involved in the regulation of breast cancer, liver cancer, prostate cancer, lung cancer and endometrial cancer, and for SOX9 (sex-determining region Y-box 9), which is the potential cervical cancer tumor suppressor that, through the activation of p21WAF1/CIP1, inhibits cervical cancer cell growth.